Evaluating Efgartigimod in Patients With Guillain-Barré Syndrome

Stopped Study will not be proceeding due to continued difficulties with participant enrollment at a single site.

Conditions

• Guillain-Barre Syndrome

Interventions

• DRUG: Efgartigimod Alfa-Fcab
• DRUG: Intravenous Immunoglobulin (IVIg)

Sponsor

Chafic Karam

Collaborators

• argenx